Artemis Wealth Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-100,000
Closed -$3.88M 134
2022
Q1
$3.88M Hold
100,000
0.64% 8
2021
Q4
$5.85M Hold
100,000
0.73% 13
2021
Q3
$5.93M Hold
100,000
0.83% 9
2021
Q2
$8.68M Hold
100,000
1.24% 9
2021
Q1
$8.25M Hold
100,000
1.29% 10
2020
Q4
$9.09M Buy
+100,000
New +$9.09M 1.45% 9